Martin Shkreli, the drug executive who was widely criticized for sharply raising the price of a drug used by HIV patients, has reportedly been arrested by federal agents on charges that he misused funds at the company he founded.
The charges have been reported by both Reuters and Bloomberg – which only yesterday was reporting on Shkreli's skills at short selling.
www.bloomberg.com/...